APO Research
Talk to an analyst

APO RESEARCH · REPORT

Middle Aged and Elderly Formula

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Middle Aged and Elderly Formula Industry Growth and Trends Forecast to 2032

5 July 202691 pages

Choose your research edition.

Industry ResearchMiddle Aged and Elderly Formula Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Middle Aged and Elderly Formula Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Middle Aged and Elderly Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Middle Aged and Elderly Formula Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Middle Aged and Elderly Formula Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Middle Aged and Elderly Formula market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Middle Aged and Elderly Formula is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Middle Aged and Elderly Formula is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Middle Aged and Elderly Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Middle Aged and Elderly Formula include Wyeth, Nestle, MeadJohnson, Abbott, Yili Group, Feihe, BEINGMATE, BIOSTIME and A2C, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Middle Aged and Elderly Formula market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Middle Aged and Elderly Formula market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Middle Aged and Elderly Formula market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Middle Aged and Elderly Formula.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Middle Aged and Elderly Formula market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Middle Aged and Elderly Formula Market by Company

Wyeth

Nestle

MeadJohnson

Abbott

Yili Group

Feihe

BEINGMATE

BIOSTIME

A2C

Middle Aged and Elderly Formula Segment by Type

Wyeth

Nestle

MeadJohnson

Abbott

Yili Group

Feihe

BEINGMATE

BIOSTIME

A2C

Middle Aged and Elderly Formula Segment by Application

Supermarket

Exclusive Shop

Online Shop

Others

Middle Aged and Elderly Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Middle Aged and Elderly Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Middle Aged and Elderly Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Middle Aged and Elderly Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Middle Aged and Elderly Formula manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Middle Aged and Elderly Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Wyeth Table 2. Major Company of Nestle Table 3. Major Company of MeadJohnson Table 4. Major Company of Abbott Table 5. Major Company of Yili Group Table 6. Major Company of Feihe Table 7. Major Company of BEINGMATE Table 8. Major Company of BIOSTIME Table 9. Major Company of A2C Table 10. Global Middle Aged and Elderly Formula Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 12. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Type (2021-2026) Table 13. Global Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 14. Global Middle Aged and Elderly Formula Sales Market Share in Value by Type (2021-2026) Table 15. Global Middle Aged and Elderly Formula Price by Type (2021-2026) & (USD/t) Table 16. Global Middle Aged and Elderly Formula Sales by Type (2027-2032) & (t) Table 17. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Type (2027-2032) Table 18. Global Middle Aged and Elderly Formula Sales by Type (2027-2032) & (US$ Million) Table 19. Global Middle Aged and Elderly Formula Sales Market Share in Value by Type (2027-2032) Table 20. Global Middle Aged and Elderly Formula Price by Type (2027-2032) & (USD/t) Table 21. North America Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 22. North America Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 24. Europe Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 26. Asia-Pacific Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 28. Latin America Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Middle Aged and Elderly Formula Sales by Type (2021-2026) & (t) Table 30. Middle East and Africa Middle Aged and Elderly Formula Sales by Type (2021-2026) & (US$ Million) Table 31. Middle Aged and Elderly Formula Industry Trends Table 32. Middle Aged and Elderly Formula Industry Drivers Table 33. Middle Aged and Elderly Formula Industry Opportunities and Challenges Table 34. Middle Aged and Elderly Formula Industry Restraints Table 35. Global Middle Aged and Elderly Formula Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Middle Aged and Elderly Formula Revenue Market Share by Company (2021-2026) Table 37. Global Middle Aged and Elderly Formula Sales by Company (2021-2026) & (t) Table 38. Global Middle Aged and Elderly Formula Sales Share by Company (2021-2026) Table 39. Global Middle Aged and Elderly Formula Market Price by Company (2021-2026) & (USD/t) Table 40. Global Middle Aged and Elderly Formula Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Middle Aged and Elderly Formula Major Company Production Sites and Headquarters Table 42. Global Middle Aged and Elderly Formula Company, Product Type & Application Table 43. Global Middle Aged and Elderly Formula Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Middle Aged and Elderly Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Middle Aged and Elderly Formula Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Middle Aged and Elderly Formula Sales by Region (2021-2026) & (t) Table 48. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Region (2021-2026) Table 49. Global Middle Aged and Elderly Formula Sales by Region (2021-2026) & (US$ Million) Table 50. Global Middle Aged and Elderly Formula Sales Market Share in Value by Region (2021-2026) Table 51. Global Middle Aged and Elderly Formula Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 52. Global Middle Aged and Elderly Formula Sales by Region (2027-2032) & (t) Table 53. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Region (2027-2032) Table 54. Global Middle Aged and Elderly Formula Sales by Region (2027-2032) & (US$ Million) Table 55. Global Middle Aged and Elderly Formula Sales Market Share in Value by Region (2027-2032) Table 56. Global Middle Aged and Elderly Formula Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 57. Global Middle Aged and Elderly Formula Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 59. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Application (2021-2026) Table 60. Global Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 61. Global Middle Aged and Elderly Formula Sales Market Share in Value by Application (2021-2026) Table 62. Global Middle Aged and Elderly Formula Price by Application (2021-2026) & (USD/t) Table 63. Global Middle Aged and Elderly Formula Sales by Application (2027-2032) & (t) Table 64. Global Middle Aged and Elderly Formula Sales Market Share in Volume by Application (2027-2032) Table 65. Global Middle Aged and Elderly Formula Sales by Application (2027-2032) & (US$ Million) Table 66. Global Middle Aged and Elderly Formula Sales Market Share in Value by Application (2027-2032) Table 67. Global Middle Aged and Elderly Formula Price by Application (2027-2032) & (USD/t) Table 68. North America Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 69. North America Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 71. Europe Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 73. Asia-Pacific Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 75. Latin America Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Middle Aged and Elderly Formula Sales by Application (2021-2026) & (t) Table 77. Middle East and Africa Middle Aged and Elderly Formula Sales by Application (2021-2026) & (US$ Million) Table 78. Wyeth Company Information Table 79. Wyeth Business Overview Table 80. Wyeth Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Wyeth Middle Aged and Elderly Formula Product Portfolio Table 82. Wyeth Recent Development Table 83. Nestle Company Information Table 84. Nestle Business Overview Table 85. Nestle Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Nestle Middle Aged and Elderly Formula Product Portfolio Table 87. Nestle Recent Development Table 88. MeadJohnson Company Information Table 89. MeadJohnson Business Overview Table 90. MeadJohnson Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. MeadJohnson Middle Aged and Elderly Formula Product Portfolio Table 92. MeadJohnson Recent Development Table 93. Abbott Company Information Table 94. Abbott Business Overview Table 95. Abbott Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Abbott Middle Aged and Elderly Formula Product Portfolio Table 97. Abbott Recent Development Table 98. Yili Group Company Information Table 99. Yili Group Business Overview Table 100. Yili Group Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Yili Group Middle Aged and Elderly Formula Product Portfolio Table 102. Yili Group Recent Development Table 103. Feihe Company Information Table 104. Feihe Business Overview Table 105. Feihe Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Feihe Middle Aged and Elderly Formula Product Portfolio Table 107. Feihe Recent Development Table 108. BEINGMATE Company Information Table 109. BEINGMATE Business Overview Table 110. BEINGMATE Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. BEINGMATE Middle Aged and Elderly Formula Product Portfolio Table 112. BEINGMATE Recent Development Table 113. BIOSTIME Company Information Table 114. BIOSTIME Business Overview Table 115. BIOSTIME Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. BIOSTIME Middle Aged and Elderly Formula Product Portfolio Table 117. BIOSTIME Recent Development Table 118. A2C Company Information Table 119. A2C Business Overview Table 120. A2C Middle Aged and Elderly Formula Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. A2C Middle Aged and Elderly Formula Product Portfolio Table 122. A2C Recent Development Table 123. North America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 124. North America Middle Aged and Elderly Formula Sales by Country (2021-2026) & (t) Table 125. North America Middle Aged and Elderly Formula Sales Market Share by Country (2021-2026) Table 126. North America Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032) & (t) Table 127. North America Middle Aged and Elderly Formula Sales Market Share Forecast by Country (2027-2032) Table 128. North America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Middle Aged and Elderly Formula Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Middle Aged and Elderly Formula Market Share by Country (2021-2026) Table 131. North America Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Middle Aged and Elderly Formula Market Share Forecast by Country (2027-2032) Table 133. Europe Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 134. Europe Middle Aged and Elderly Formula Sales by Country (2021-2026) & (t) Table 135. Europe Middle Aged and Elderly Formula Sales Market Share by Country (2021-2026) Table 136. Europe Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032) & (t) Table 137. Europe Middle Aged and Elderly Formula Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Middle Aged and Elderly Formula Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Middle Aged and Elderly Formula Market Share by Country (2021-2026) Table 141. Europe Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Middle Aged and Elderly Formula Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Middle Aged and Elderly Formula Sales by Country (2021-2026) & (t) Table 145. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032) & (t) Table 147. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Middle Aged and Elderly Formula Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Middle Aged and Elderly Formula Market Share by Country (2021-2026) Table 151. Asia-Pacific Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Middle Aged and Elderly Formula Market Share Forecast by Country (2027-2032) Table 153. Latin America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 154. Latin America Middle Aged and Elderly Formula Sales by Country (2021-2026) & (t) Table 155. Latin America Middle Aged and Elderly Formula Sales Market Share by Country (2021-2026) Table 156. Latin America Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032) & (t) Table 157. Latin America Middle Aged and Elderly Formula Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Middle Aged and Elderly Formula Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Middle Aged and Elderly Formula Market Share by Country (2021-2026) Table 161. Latin America Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Middle Aged and Elderly Formula Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Middle Aged and Elderly Formula Sales by Country (2021-2026) & (t) Table 165. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032) & (t) Table 167. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Middle Aged and Elderly Formula Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Middle Aged and Elderly Formula Market Share by Country (2021-2026) Table 171. Middle East and Africa Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Middle Aged and Elderly Formula Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Middle Aged and Elderly Formula Distributors List Table 176. Middle Aged and Elderly Formula Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Middle Aged and Elderly Formula Image Figure 2. Global Middle Aged and Elderly Formula Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Middle Aged and Elderly Formula Market Size (2021-2032) & (US$ Million) Figure 4. Global Middle Aged and Elderly Formula Sales (2021-2032) & (t) Figure 5. Wyeth Image Figure 6. Global Wyeth Sales YoY Growth (2021-2032) & (t) Figure 7. Nestle Image Figure 8. Global Nestle Sales YoY Growth (2021-2032) & (t) Figure 9. MeadJohnson Image Figure 10. Global MeadJohnson Sales YoY Growth (2021-2032) & (t) Figure 11. Abbott Image Figure 12. Global Abbott Sales YoY Growth (2021-2032) & (t) Figure 13. Yili Group Image Figure 14. Global Yili Group Sales YoY Growth (2021-2032) & (t) Figure 15. Feihe Image Figure 16. Global Feihe Sales YoY Growth (2021-2032) & (t) Figure 17. BEINGMATE Image Figure 18. Global BEINGMATE Sales YoY Growth (2021-2032) & (t) Figure 19. BIOSTIME Image Figure 20. Global BIOSTIME Sales YoY Growth (2021-2032) & (t) Figure 21. A2C Image Figure 22. Global A2C Sales YoY Growth (2021-2032) & (t) Figure 23. Global Middle Aged and Elderly Formula Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Middle Aged and Elderly Formula Market Share by Type 2025 VS 2032 Figure 25. North America Middle Aged and Elderly Formula Sales Market Share in Volume by Type in 2025 Figure 26. North America Middle Aged and Elderly Formula Sales Market Share in Value by Type in 2025 Figure 27. Europe Middle Aged and Elderly Formula Sales Market Share in Volume by Type in 2025 Figure 28. Europe Middle Aged and Elderly Formula Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share in Value by Type in 2025 Figure 31. Latin America Middle Aged and Elderly Formula Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Middle Aged and Elderly Formula Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Middle Aged and Elderly Formula Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Supermarket Image Figure 38. Global Supermarket Sales YoY Growth (2021-2032) & (t) Figure 39. Exclusive Shop Image Figure 40. Global Exclusive Shop Sales YoY Growth (2021-2032) & (t) Figure 41. Online Shop Image Figure 42. Global Online Shop Sales YoY Growth (2021-2032) & (t) Figure 43. Others Image Figure 44. Global Others Sales YoY Growth (2021-2032) & (t) Figure 45. Global Middle Aged and Elderly Formula Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Middle Aged and Elderly Formula Market Share by Application 2025 VS 2032 Figure 47. North America Middle Aged and Elderly Formula Sales Market Share in Volume by Application in 2025 Figure 48. North America Middle Aged and Elderly Formula Sales Market Share in Value by Application in 2025 Figure 49. Europe Middle Aged and Elderly Formula Sales Market Share in Volume by Application in 2025 Figure 50. Europe Middle Aged and Elderly Formula Sales Market Share in Value by Application in 2025 Figure 51. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share in Volume by Application in 2025 Figure 52. Asia-Pacific Middle Aged and Elderly Formula Sales Market Share in Value by Application in 2025 Figure 53. Latin America Middle Aged and Elderly Formula Sales Market Share in Volume by Application in 2025 Figure 54. Latin America Middle Aged and Elderly Formula Sales Market Share in Value by Application in 2025 Figure 55. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share in Volume by Application in 2025 Figure 56. Middle East and Africa Middle Aged and Elderly Formula Sales Market Share in Value by Application in 2025 Figure 57. North America Middle Aged and Elderly Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. North America Middle Aged and Elderly Formula Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. North America Middle Aged and Elderly Formula Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. North America Middle Aged and Elderly Formula Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Middle Aged and Elderly Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Europe Middle Aged and Elderly Formula Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Middle Aged and Elderly Formula Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Europe Middle Aged and Elderly Formula Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Middle Aged and Elderly Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 66. Asia-Pacific Middle Aged and Elderly Formula Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Middle Aged and Elderly Formula Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Asia-Pacific Middle Aged and Elderly Formula Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Middle Aged and Elderly Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 70. Latin America Middle Aged and Elderly Formula Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Middle Aged and Elderly Formula Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Latin America Middle Aged and Elderly Formula Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Middle Aged and Elderly Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 74. Middle East and Africa Middle Aged and Elderly Formula Sales Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Middle Aged and Elderly Formula Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 76. Middle East and Africa Middle Aged and Elderly Formula Market Share by Country: 2021 VS 2025 VS 2032 Figure 77. Middle Aged and Elderly Formula Value Chain Figure 78. Key Raw Materials Price Figure 79. Manufacturing Cost Structure Figure 80. Middle Aged and Elderly Formula Production Mode & Process Figure 81. Direct Comparison with Distribution Share Figure 82. Distributors Profiles Figure 83. Years Considered Figure 84. Research Process Figure 85. Key Executives Interviewed

Scope & coverage.

Types
  • Wyeth
  • Nestle
  • MeadJohnson
  • Abbott
  • Yili Group
  • Feihe
  • BEINGMATE
  • BIOSTIME
  • A2C
Applications
  • Supermarket
  • Exclusive Shop
  • Online Shop
  • Others
Companies covered
  • Wyeth
  • Nestle
  • MeadJohnson
  • Abbott
  • Yili Group
  • Feihe
  • BEINGMATE
  • BIOSTIME
  • A2C

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Middle Aged and Elderly Formula Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Middle Aged and Elderly Formula Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Middle Aged and Elderly Formula Market by Type
  6. 1.3.1 Wyeth
  7. 1.3.2 Nestle
  8. 1.3.3 MeadJohnson
  9. 1.3.4 Abbott
  10. 1.3.5 Yili Group
  11. 1.3.6 Feihe
  12. 1.3.7 BEINGMATE
  13. 1.3.8 BIOSTIME
  14. 1.3.9 A2C
  15. 1.4 Global Middle Aged and Elderly Formula Market Size by Type
  16. 1.4.1 Global Middle Aged and Elderly Formula Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Middle Aged and Elderly Formula Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Middle Aged and Elderly Formula Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Middle Aged and Elderly Formula Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Middle Aged and Elderly Formula Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Middle Aged and Elderly Formula Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Middle Aged and Elderly Formula Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Middle Aged and Elderly Formula Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Middle Aged and Elderly Formula Industry Trends
  2. 2.2 Middle Aged and Elderly Formula Industry Drivers
  3. 2.3 Middle Aged and Elderly Formula Industry Opportunities and Challenges
  4. 2.4 Middle Aged and Elderly Formula Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Middle Aged and Elderly Formula Revenue (2021-2026)
  2. 3.2 Global Top Players by Middle Aged and Elderly Formula Sales (2021-2026)
  3. 3.3 Global Top Players by Middle Aged and Elderly Formula Price (2021-2026)
  4. 3.4 Global Middle Aged and Elderly Formula Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Middle Aged and Elderly Formula Major Company Production Sites & Headquarters
  6. 3.6 Global Middle Aged and Elderly Formula Company, Product Type & Application
  7. 3.7 Global Middle Aged and Elderly Formula Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Middle Aged and Elderly Formula Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Middle Aged and Elderly Formula Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Middle Aged and Elderly Formula Tier 1, Tier 2, and Tier 3
4 Middle Aged and Elderly Formula Regional Status and Outlook
  1. 4.1 Global Middle Aged and Elderly Formula Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Middle Aged and Elderly Formula Historic Market Size by Region
  3. 4.2.1 Global Middle Aged and Elderly Formula Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Middle Aged and Elderly Formula Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Middle Aged and Elderly Formula Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Middle Aged and Elderly Formula Forecasted Market Size by Region
  7. 4.3.1 Global Middle Aged and Elderly Formula Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Middle Aged and Elderly Formula Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Middle Aged and Elderly Formula Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Middle Aged and Elderly Formula by Application
  1. 5.1 Middle Aged and Elderly Formula Market by Application
  2. 5.1.1 Supermarket
  3. 5.1.2 Exclusive Shop
  4. 5.1.3 Online Shop
  5. 5.1.4 Others
  6. 5.2 Global Middle Aged and Elderly Formula Market Size by Application
  7. 5.2.1 Global Middle Aged and Elderly Formula Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Middle Aged and Elderly Formula Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Middle Aged and Elderly Formula Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Middle Aged and Elderly Formula Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Middle Aged and Elderly Formula Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Middle Aged and Elderly Formula Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Middle Aged and Elderly Formula Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Middle Aged and Elderly Formula Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wyeth
  2. 6.1.1 Wyeth Company Information
  3. 6.1.2 Wyeth Business Overview
  4. 6.1.3 Wyeth Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wyeth Middle Aged and Elderly Formula Product Portfolio
  6. 6.1.5 Wyeth Recent Developments
  7. 6.2 Nestle
  8. 6.2.1 Nestle Company Information
  9. 6.2.2 Nestle Business Overview
  10. 6.2.3 Nestle Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nestle Middle Aged and Elderly Formula Product Portfolio
  12. 6.2.5 Nestle Recent Developments
  13. 6.3 MeadJohnson
  14. 6.3.1 MeadJohnson Company Information
  15. 6.3.2 MeadJohnson Business Overview
  16. 6.3.3 MeadJohnson Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MeadJohnson Middle Aged and Elderly Formula Product Portfolio
  18. 6.3.5 MeadJohnson Recent Developments
  19. 6.4 Abbott
  20. 6.4.1 Abbott Company Information
  21. 6.4.2 Abbott Business Overview
  22. 6.4.3 Abbott Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Middle Aged and Elderly Formula Product Portfolio
  24. 6.4.5 Abbott Recent Developments
  25. 6.5 Yili Group
  26. 6.5.1 Yili Group Company Information
  27. 6.5.2 Yili Group Business Overview
  28. 6.5.3 Yili Group Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Yili Group Middle Aged and Elderly Formula Product Portfolio
  30. 6.5.5 Yili Group Recent Developments
  31. 6.6 Feihe
  32. 6.6.1 Feihe Company Information
  33. 6.6.2 Feihe Business Overview
  34. 6.6.3 Feihe Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Feihe Middle Aged and Elderly Formula Product Portfolio
  36. 6.6.5 Feihe Recent Developments
  37. 6.7 BEINGMATE
  38. 6.7.1 BEINGMATE Company Information
  39. 6.7.2 BEINGMATE Business Overview
  40. 6.7.3 BEINGMATE Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BEINGMATE Middle Aged and Elderly Formula Product Portfolio
  42. 6.7.5 BEINGMATE Recent Developments
  43. 6.8 BIOSTIME
  44. 6.8.1 BIOSTIME Company Information
  45. 6.8.2 BIOSTIME Business Overview
  46. 6.8.3 BIOSTIME Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BIOSTIME Middle Aged and Elderly Formula Product Portfolio
  48. 6.8.5 BIOSTIME Recent Developments
  49. 6.9 A2C
  50. 6.9.1 A2C Company Information
  51. 6.9.2 A2C Business Overview
  52. 6.9.3 A2C Middle Aged and Elderly Formula Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 A2C Middle Aged and Elderly Formula Product Portfolio
  54. 6.9.5 A2C Recent Developments
7 North America by Country
  1. 7.1 North America Middle Aged and Elderly Formula Sales by Country
  2. 7.1.1 North America Middle Aged and Elderly Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Middle Aged and Elderly Formula Sales by Country (2021-2026)
  4. 7.1.3 North America Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032)
  5. 7.2 North America Middle Aged and Elderly Formula Market Size by Country
  6. 7.2.1 North America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Middle Aged and Elderly Formula Market Size by Country (2021-2026)
  8. 7.2.3 North America Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Middle Aged and Elderly Formula Sales by Country
  2. 8.1.1 Europe Middle Aged and Elderly Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Middle Aged and Elderly Formula Sales by Country (2021-2026)
  4. 8.1.3 Europe Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Middle Aged and Elderly Formula Market Size by Country
  6. 8.2.1 Europe Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Middle Aged and Elderly Formula Market Size by Country (2021-2026)
  8. 8.2.3 Europe Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Middle Aged and Elderly Formula Sales by Country
  2. 9.1.1 Asia-Pacific Middle Aged and Elderly Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Middle Aged and Elderly Formula Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Middle Aged and Elderly Formula Market Size by Country
  6. 9.2.1 Asia-Pacific Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Middle Aged and Elderly Formula Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Middle Aged and Elderly Formula Sales by Country
  2. 10.1.1 South America Middle Aged and Elderly Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Middle Aged and Elderly Formula Sales by Country (2021-2026)
  4. 10.1.3 South America Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032)
  5. 10.2 South America Middle Aged and Elderly Formula Market Size by Country
  6. 10.2.1 South America Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Middle Aged and Elderly Formula Market Size by Country (2021-2026)
  8. 10.2.3 South America Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Middle Aged and Elderly Formula Sales by Country
  2. 11.1.1 Middle East and Africa Middle Aged and Elderly Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Middle Aged and Elderly Formula Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Middle Aged and Elderly Formula Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Middle Aged and Elderly Formula Market Size by Country
  6. 11.2.1 Middle East and Africa Middle Aged and Elderly Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Middle Aged and Elderly Formula Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Middle Aged and Elderly Formula Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Middle Aged and Elderly Formula Value Chain Analysis
  2. 12.1.1 Middle Aged and Elderly Formula Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Middle Aged and Elderly Formula Production Mode & Process
  7. 12.2 Middle Aged and Elderly Formula Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Middle Aged and Elderly Formula Distributors
  10. 12.2.3 Middle Aged and Elderly Formula Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst